The rising cost of healthcare in the United States is a matter of great concern for both individuals and policymakers. Among the many factors contributing to this crisis, one often overlooked is the role of insurers and Pharmacy Benefit Managers (PBMs) in inflating drug prices. While these entities are designed to control costs and make healthcare more accessible, they sometimes use practices that drive up drug prices.